一例间变性少突胶质细胞瘤的多模态18F-氟昔洛韦PET/MRI与超声引导神经外科手术
本文报告首例使用氨基酸示踪剂18F-氟昔洛韦(18F-FACBC)进行同步PET/MRI检查并用于术中影像引导手术的脑胶质瘤患者。一例60岁女性因言语困难和左侧轻偏瘫就诊,MRI提示胶质瘤,术前接受同步PET/MRI,融合PET/MRI、T1、FLAIR及术中三维超声图像引导组织取样与切除。组织病理显示肿瘤最恶性部分为间变性少突胶质细胞瘤,部分区域为WHO II级;18F-氟昔洛韦摄取见于WHO分级、细胞增殖和细胞密度最高的区域。
要点
- 首例使用18F-氟昔洛韦PET/MRI进行术中影像引导手术的脑胶质瘤患者。
- 18F-氟昔洛韦摄取见于WHO分级、细胞增殖和细胞密度最高的肿瘤区域。
- 该示踪剂PET/MRI可能提高组织取样和分级的准确性,并可能指导针对最恶性部分的治疗。
核心结论
- 18F-氟昔洛韦摄取见于肿瘤中区域WHO分级、细胞增殖和细胞密度最高的部分,提示该示踪剂PET/MRI可能提高组织病理取样和分级的准确性,并可能用于指导针对广泛且位于功能区的胶质瘤最恶性部分的治疗。
研究设计与样本
- 病例报告,报告首例使用18F-氟昔洛韦(18F-FACBC)进行同步PET/MRI并用于术中影像引导手术的脑胶质瘤患者。
主要发现
- 一例60岁女性因言语困难和左侧轻偏瘫就诊,MRI显示提示胶质瘤的肿瘤。
- 术前进行同步PET/MRI,融合PET/MRI、T1、FLAIR和术中三维超声图像用于引导组织取样和手术切除。
- 组织病理分析显示肿瘤最恶性部分为间变性少突胶质细胞瘤,而多个区域为WHO II级。
- 18F-氟昔洛韦摄取见于区域WHO分级、细胞增殖和细胞密度最高的肿瘤部分。
临床怎么用
- 作者认为,使用该示踪剂的PET/MRI可能提高组织病理取样和分级的准确性,并可能用于指导针对广泛且位于功能区的胶质瘤最恶性部分的治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Structural magnetic resonance imaging (MRI) and histopathologic tissue sampling are routinely performed as part of the diagnostic workup for patients with glioma. Because of the heterogeneous nature of gliomas, there is a risk of undergrading caused by histopathologic sampling errors. MRI has limitations in identifying tumor grade and type, detecting diffuse invasive growth, and separating recurrences from treatment induced changes. Positron emission tomography (PET) can provide quantitative information of cellular activity and metabolism, and may therefore complement MRI. In this report, we present the first patient with brain glioma examined with simultaneous PET/MRI using the amino acid tracer 18F-fluciclovine (18F-FACBC) for intraoperative image-guided surgery. CASE DESCRIPTION: A previously healthy 60-year old woman was admitted to the emergency care with speech difficulties and a mild left-sided hemiparesis. MRI revealed a tumor that was suggestive of glioma. Before surgery, the patient underwent a simultaneous PET/MRI examination. Fused PET/MRI, T1, FLAIR, and intraoperative three-dimensional ultrasound images were used to guide histopathologic tissue sampling and surgical resection. Navigated, image-guided histopathologic samples were compared with PET/MRI image data to assess the additional value of the PET acquisition. Histopathologic analysis showed anaplastic oligodendroglioma in the most malignant parts of the tumor, while several regions were World Health Organization (WHO) grade II. CONCLUSIONS: 18F-Fluciclovine uptake was found in parts of the tumor where regional WHO grade, cell proliferation, and cell densities were highest. This finding suggests that PET/MRI with this tracer could be used to improve accuracy in histopathologic tissue sampling and grading, and possibly for guiding treatments targeting the most malignant part of extensive and eloquent gliomas.
引用
- Karlberg A, Berntsen EM, Johansen H, et al. Multimodal 18F-Fluciclovine PET/MRI and Ultrasound-Guided Neurosurgery of an Anaplastic Oligodendroglioma. World Neurosurg. 2017. PMID: 28844925. doi:10.1016/j.wneu.2017.08.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。